系统性红斑狼疮持续存在的死亡率差距:挪威1999-2022年基于人群的幼年起病与成年起病SLE研究
基于挪威东南部Nor-SLE队列1558例SLE患者(其中749例为发病病例并符合2019-EULAR/ACR分类标准),评估死亡率和生存率。发病成年起病SLE的标准化死亡率比(SMR)为1.8(95%CI 1.6-2.2),幼年起病SLE(n=93)SMR峰值达7.2(95%CI 3.3-14),且随诊断年龄增加逐渐下降。研究显示成年起病SLE与对照人群之间的死亡率差距持续存在,幼年起病SLE死亡率令人担忧地高。
要点
- 发病成年起病SLE的SMR为1.8(95%CI 1.6-2.2),女性与男性间无差异。
- 幼年起病SLE(n=93)SMR峰值达7.2(95%CI 3.3-14),随诊断年龄增加逐渐下降。
- 多变量分析中狼疮肾炎与生存率降低相关,性别无此关联。
核心结论
- 研究显示成年起病SLE与对照人群之间的死亡率差距在人群水平持续存在,并提示幼年起病SLE死亡率令人担忧地高。
研究设计与样本
- 幼年起病SLE定义为诊断时年龄<16岁;SMR估计时按年龄、性别、居住地和族裔为每例患者匹配15名人群对照。
- 采用Kaplan-Meier分析生存率,Cox回归分析危险因素。
主要发现
- Nor-SLE队列共纳入1558例SLE病例,其中749例为发病病例并符合2019年EULAR和ACR(2019-EA)分类标准。
- 发病成年起病SLE的SMR升高至1.8(95%CI 1.6-2.2),女性与男性间无差异。
- 发病成年起病SLE在5年、10年、15年和20年的生存率均低于匹配对照。
- 多变量分析中狼疮肾炎与生存率降低相关,性别与生存率降低无关。
- 在总Nor-SLE队列的长期死亡分析中,幼年起病SLE(n=93)的SMR峰值达7.2(95%CI 3.3-14),并随SLE诊断年龄增加逐渐下降。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To estimate mortality and survival rates of SLE in a contemporary, population-based setting and assess potential influences by time, sex, ethnicity, classification criteria and age at diagnosis. METHODS: We assessed mortality and survival in the Nor-SLE cohort, which includes all chart review-confirmed SLE cases resident in Southeast Norway (population 2.9 million) 1999-2017. Study end was at death, emigration or 1 October 2022. We defined juvenile SLE by age <16 years at diagnosis. For standardized mortality rate (SMR) estimates, we applied 15 population controls per case, all matched for age, sex, residency and ethnicity. We analysed survival by Kaplan-Meier and risk factors by Cox regression. RESULTS: The Nor-SLE cohort included 1558 SLE cases, of whom 749 were incident and met the 2019 EULAR and ACR (2019-EA) classification criteria. SMR was increased to 1.8 (95% CI 1.6-2.2) in incident adult-onset SLE but did not differ between females and males. Survival rates at 5, 10, 15 and 20 years were lower in incident adult-onset SLE than in matched controls. In multivariable analysis, LN associated with decreased survival, while sex did not. Separate, long-term mortality analyses in the total Nor-SLE cohort showed that SMR peaked at 7.2 (95% CI 3.3-14) in juvenile-onset SLE (n = 93) and fell gradually by increasing age at SLE diagnosis. CONCLUSION: This study shows persistence of a mortality gap between adult-onset SLE and controls at population level and provides indications of worryingly high mortality in juvenile-onset SLE.
引用
- Moe SR, Haukeland H, Brunborg C, et al. Persisting mortality gap in systemic lupus erythematosus; a population-based study on juvenile- and adult-onset SLE in Norway 1999-2022. Rheumatology (Oxford). 2024. PMID: 37769251. doi:10.1093/rheumatology/kead519
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。